NO974846L - Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid - Google Patents

Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid

Info

Publication number
NO974846L
NO974846L NO974846A NO974846A NO974846L NO 974846 L NO974846 L NO 974846L NO 974846 A NO974846 A NO 974846A NO 974846 A NO974846 A NO 974846A NO 974846 L NO974846 L NO 974846L
Authority
NO
Norway
Prior art keywords
ranitidine hydrochloride
preparation
ranitidine
hydrochloride
methyl
Prior art date
Application number
NO974846A
Other languages
English (en)
Norwegian (no)
Other versions
NO974846D0 (no
Inventor
Helmut Schickaneder
Aggelos Nikolopoulos
Original Assignee
Hexal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Pharmaceuticals Inc filed Critical Hexal Pharmaceuticals Inc
Publication of NO974846D0 publication Critical patent/NO974846D0/no
Publication of NO974846L publication Critical patent/NO974846L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO974846A 1995-04-21 1997-10-20 Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid NO974846L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/426,930 US5663381A (en) 1995-04-21 1995-04-21 Process for preparing form 1 ranitidine hydrochloride
PCT/US1996/000992 WO1996033185A1 (en) 1995-04-21 1996-01-26 A process for preparing form 1 ranitidine hydrochloride

Publications (2)

Publication Number Publication Date
NO974846D0 NO974846D0 (no) 1997-10-20
NO974846L true NO974846L (no) 1997-12-19

Family

ID=23692783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974846A NO974846L (no) 1995-04-21 1997-10-20 Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid

Country Status (17)

Country Link
US (1) US5663381A (sv)
JP (1) JPH11503755A (sv)
KR (1) KR19990007912A (sv)
AU (1) AU691736B2 (sv)
BG (1) BG101982A (sv)
BR (1) BR9608177A (sv)
CA (1) CA2218562A1 (sv)
CZ (1) CZ332097A3 (sv)
EE (1) EE9700291A (sv)
FI (1) FI974002A (sv)
HU (1) HUP9801658A2 (sv)
NO (1) NO974846L (sv)
NZ (1) NZ302872A (sv)
PL (1) PL322979A1 (sv)
SI (1) SI9620056A (sv)
SK (1) SK143697A3 (sv)
WO (1) WO1996033185A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004985A (en) * 1996-10-09 1999-12-21 Berlex Laboratories, Inc. Thio acid derived monocylic N-heterocyclics as anticoagulants
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
IT1317858B1 (it) 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
ATE543817T1 (de) * 2003-07-29 2012-02-15 Dainippon Sumitomo Pharma Co Verfahren zur herstellung einer imidverbindung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
JPH11503755A (ja) 1999-03-30
HUP9801658A2 (hu) 1999-09-28
WO1996033185A1 (en) 1996-10-24
MX9708122A (es) 1998-06-28
BG101982A (en) 1998-04-30
KR19990007912A (ko) 1999-01-25
AU691736B2 (en) 1998-05-21
CA2218562A1 (en) 1996-10-24
NO974846D0 (no) 1997-10-20
FI974002A (sv) 1997-12-03
AU4903296A (en) 1996-11-07
EE9700291A (et) 1998-06-15
PL322979A1 (en) 1998-03-02
CZ332097A3 (cs) 1998-03-18
SI9620056A (sl) 1998-04-30
SK143697A3 (en) 1998-05-06
US5663381A (en) 1997-09-02
BR9608177A (pt) 2000-10-31
NZ302872A (en) 1998-04-27
FI974002A0 (sv) 1997-10-20

Similar Documents

Publication Publication Date Title
ES2163511T3 (es) Preparacion farmaceutica conteniendo glucagon.
NO965298D0 (no) Ny krystallmodifikasjon av CDCH, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende denne
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
PL293795A1 (en) Method of obtaining cyclic urea derivatives
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
PL313070A1 (en) Derivatives of n-(3-benzofuranyl)-urea, method of obtaining them and pharmaceutical compositions containing such derivatives
HUP9603237A2 (hu) (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
DK0830126T3 (da) Stabiliserede pseudo-emulsioner og fremgangsmåde til fremstilling deraf
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
DE59601683D1 (de) Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
HUP9801977A1 (hu) Új indol- és indazolszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
NO974846L (no) Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
HUP0105308A2 (hu) Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
EE03803B1 (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
HUP9900668A2 (hu) Szulfamidsavszármazékok, N-acil-szulfonamidok és szulfonil-karbamát-származékok alkalmazása lipoproteinszintet csökkentő gyógyászati készítmények előállítására
HUP0004507A1 (hu) Ketolidok alkalmazása atheroszklerózissal kapcsolatos artériás trombózis- komplikációk megelőzésére alkalmas gyógyszerkészítmény előállítására
DE3773800D1 (de) Proteinsyntheseinhibitor, verfahren zu seiner herstellung, verwendung und diesen enthaltende pharmazeutische zusammensetzungen.
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
DE69707603D1 (de) Verfahren zur Herstellung von N2-Arylsulfonyl-L-Argininamiden